IUHSA
BBIO icon

Itau Unibanco Holding S.A.’s BridgeBio Pharma BBIO Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63K Sell
846
-2
-0.2% -$140 ﹤0.01% 272
2026
Q1 		$63K Buy
848
+29
+4% +$2.1K ﹤0.01% 229
2025
Q4 		$62.6K Sell
819
-651
-44% -$42.7K ﹤0.01% 216
2025
Q3 		$76.4K Sell
1,470
-9
-0.6% -$439 ﹤0.01% 208
2025
Q2 		$63.9K Sell
1,479
-19
-1% -$691 ﹤0.01% 229
2025
Q1 		$52K Hold
1,498
– – ﹤0.01% 255
2024
Q4 		$41.1K Buy
+1,498
New +$38.7K ﹤0.01% 287
2024
Q3 		– Sell
-153
Closed -$3.88K – 340
2024
Q2 		$3.88K Buy
+153
New +$4.18K ﹤0.01% 329
2024
Q1 		– Sell
-260
Closed -$10.5K – 147
2023
Q4 		$10.5K Buy
+260
New +$7.81K ﹤0.01% 312
2023
Q2 		– Sell
-2,144
Closed -$35.5K – 519
2023
Q1 		$35.5K Sell
2,144
-12
-0.6% -$140 ﹤0.01% 362
2022
Q4 		$16.4K Sell
2,156
-654
-23% -$6.26K ﹤0.01% 410
2022
Q3 		$28K Buy
+2,810
New +$29.2K ﹤0.01% 419
2022
Q2 		– Sell
-203
Closed -$2K – 481
2022
Q1 		$2K Hold
203
– – ﹤0.01% 454
2021
Q4 		$3K Buy
203
+18
+10% +$762 ﹤0.01% 402
2021
Q3 		$9K Buy
185
+5
+3% +$268 ﹤0.01% 371
2021
Q2 		$11K Buy
+180
New +$10.3K ﹤0.01% 333

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Itau Unibanco Holding S.A.'s BBIO Position: Q2 2026 in Review

Itau Unibanco Holding S.A. reduced its BridgeBio Pharma (BBIO) stake by 0.24% in Q2 2026, selling an estimated $140 and leaving 846 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Itau Unibanco Holding S.A. first reported a position in BBIO in Q2 2021 and has held it in 16 quarters since. The position peaked at $76.4K in Q3 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Itau Unibanco Holding S.A. held 846 shares of BridgeBio Pharma worth $63K as of Q2 2026.
  • Itau Unibanco Holding S.A. sold 2 BridgeBio Pharma shares in Q2 2026, an estimated $140.
  • BridgeBio Pharma made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q2 2026, its #272 holding.
  • Itau Unibanco Holding S.A. first reported a position in BridgeBio Pharma in Q2 2021 and has held it in 16 quarters since.
  • Itau Unibanco Holding S.A.'s BridgeBio Pharma position peaked at $76.4K in Q3 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.